Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 May 2022 for Oxford BioDynamics Plc, €51.
Filing timeline
BuySaleMatthew Wakefield
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -3.9%Entry £0.18 · Close at T+365 £0.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Matthew Wakefield: trading record in brief
Only one filing by Matthew Wakefield is known so far (20 May 2022): an open-market purchase, €51, in Oxford BioDynamics PLC. That is too little to draw conclusions. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Wakefield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 25,000 shares@ £0.0017100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD5H8572FCA-NSM:4378523Canonical exit: 18 Aug 2022 (T+90)
1 of 1 declaration